Monarch Bronchoscope
Reprocessed Bronchoscope. 510(k) K231473, from Auris Health, Inc., A Johnson and Johnson Family Company (Redwood, CA). Product code QNW, class 2.
As of Nov 17, 2026, K231473 is an FDA 510(k) held by Auris Health, Inc., A Johnson and Johnson Family Company, substantially equivalent on Nov 28, 2023 after 190 days, with 1 recall tied to it in FDA's recall database.
- Substantially equivalent: Nov 28, 2023
- Review time: 190 days
- Recalls: 1
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe reprocessed Monarch Bronchoscope, used in conjunction with the Monarch Platform, is intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Monarch BronchoscopeK203614 · Auris Health, Inc., A Johnson and Johnson Family Company · Mar 11, 2021
- Monarch PlatformK193534 · Auris Health, Inc. · Apr 15, 2020
Recalls
Recalls FDA ties to K231473, newest first; each opens FDA's recall record| Started | Reason | Status |
|---|---|---|
| Oct 18, 2025 | Z-0543-2026Potential that product was leak tested with equipment outside of its expected operating range, resulting in bronchoscopes that may not be susceptible to leaks. | Open, Classified |
Other QNW Clearances
The newest 510(k)s for the same product code; see every QNW device- Monarch BronchoscopeK203614 · Auris Health, Inc., A Johnson and Johnson Family Company · Mar 11, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 22, 2023
- Review panel
- Ear, Nose, Throat
- Regulation
- 21 CFR 874.4680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files